The global Pharma & Biotech CRM Software Market is expected to experience significant growth, with revenue projected to increase from US$ 4,528.4 million in 2021 to US$ 10,830.2 million by 2027. This growth is driven by factors such as enhanced customer relationship management, technological advancements, and regulatory compliance.
